$INJ

Injective Protocol (INJ) is trading at approximately $25.54 with a market capitalization of $2.43 billion as of November 2024. The asset has recently demonstrated strong growth, driven by its low transaction fees, token-burning mechanism, and innovative offerings in decentralized finance (DeFi), such as cross-chain margin trading and derivatives. This has made it an attractive platform for traders seeking alternatives to centralized exchanges.

Injective burns 60% of trading fees weekly, gradually reducing its token supply, which could create upward price pressure over time.

With transaction fees as low as $0.0003, Injective stands out as one of the most cost-effective blockchains.

It supports integration with major chains like Ethereum, Solana, and Cosmos, enhancing its utility across the DeFi space.

Growing EcosystemContinued upgrades and the addition of non-trading protocols could broaden its use cases and attract more users.

Analysts predict a potential price range of $7.87 (bearish) to $52.90 (bullish), depending on market sentiment and broader crypto adoption trends.

Predictions suggest INJ could trade between $23.50 and $37.29, with bullish scenarios pointing higher if adoption grows.

Long-term forecasts are highly optimistic, with some analysts projecting prices exceeding $200 if the token-burning mechanism continues to shrink supply and demand remains strong.